Drug Discovery: Easing the Chemistry Bottleneck - Conference Details

2nd Annual

Drug Discovery:

Easing The Bottleneck


August 23-24, 2010
Loews Philadelphia Hotel, Philadelphia, PA

VIEW CURRENT AGENDA (as of 7/28/10)    SUGGEST A SPEAKER   

See This Year's Attendees

Conference Details:

In an effort to help the pharmaceutical industry streamline the process of getting lifesaving drugs and technologies to market, We are proud to present our annual Drug Discovery: Easing the Bottleneck Conference. With key products suffering patent expiration in coming years, we understand the need to produce new and innovative products, and get them to market without suffering the fate of many drugs on the pipeline. By gathering together at this drug discovery conference the foremost experts on issues such as compound management innovation and strategies, gene expression strategies, and other pertinent and debated topics we hope to open up a dialog which will lead to improved speed to market, increased profit margins, and most importantly: new and effective drugs and biotechnology.

Conference Registration Prices:
Pharmaceutical Manufacturer Standard Price- $995

All other guests
Standard Registration - $1895

If you are interested in speaking or possible sponsorship opportunities, please contact Kira O’Brien at KOBrien@opalevents.org or 212.532.9898 x263 for more details

Register for this event

Current Conference Composition as of (7/26/10)

 
 
   

Keynote:


Chagutum Rathnam

Rathnam Chaguturu
Director, High Throughput Screening Laboratory, University of Kansas

Keynote Talk: Emerging Trends in Open Source Drug Discovery: Uncorking the Bottleneck

To read Rathnam Chaguturu's full bio, click here.


   

Speaking Faculty to Date:

Dr. Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Centre
Dr. Jean-Claude Bradley, Associate Professor of Chemistry and E-Learning Coordinator, Drexel University 
Dr. Manori Turmel, Principal Scientist, Compound Management and Automation, AstraZeneca
Dr. Joseph Cesarone, Principal Research Computer Scientist, Scientific Informatics & Automation, Abbott Laboratories
Dr. David Schultz, 
Director, Protein Production, Libraries and Molecular Screening Facility, Wistar Scientist, Wistar Institute
Dr. Gordon Todderud, Lead Evaluation, Bristol-Meyers Squibb 
Dr. Pierre Baillargeon, Compound Manager, Scripps Research Institute 
Melissa Crisp, Research Associate, The Scripps Research Institute
Dileep Monie, Research Associate, Profectus BioSciences 
Scott Mosser, Senior Research Associate and Drug Discovery Manager, Merck & Co
Dr. Mark Scheideler, Senior Scientific Officer, Office of Translational Research, NIH
Dr. Melvin Reichman, Director of the LIMR Chemical Genomics Center, Lankenau Institute for Medical Research
Dr. Scott Dax
,Vice President of Chemistry, Galleon Pharmaceuticals
Ricardo Macarron, VP of Sample Management, GlaxoSmithKline
William Strohl, VP of Biologics Research, Johnson & Johnson
Norman D. Huebert, Principal Team Leader, Johnson & Johnson
Paul McCoy, Principal Automation Engineer, Lundbeck Research
Dr. Rakesh Dixit, Vice President of R & D, Global Head, Biologics Safety Assessment, MedImmune
Hugo Geerts, Associate Professor, University of Pennsylvania
Dr. Albert Giovenella, Adjunct Professor, University of Pennsylvania Medical School
Dr. Rakesh Rathore, Drug Discovery Group, University of Cincinnati
Dr. Nathan Moerke,
Senior Cancer Assay Developer, ICCB Longwood Screening Facility, Harvard Medical School
Dr. Weir-Wu He,
Founder and CEO, OriGene Technologies 
Walter Cedeno,
Principal Scientist, Research & Early Development Informatics, Johnson and Johnson
Dr. Raj Nagaraja,
Senior Associate Director, DDS-DMPK, Boehringer-Ingelheim Pharmaceuticals
Edward Pierson,
Global Product Manager, AstraZeneca Pharmaceuticals
Dr. James Campbell,
Director of Lead Generation, AstraZeneca Pharmaceuticals
Keith Miller,  
Research Automation Engineer, Pfizer
Dr. Richard Somberg,
Strategic Collaborations Manager, Promega
Dr. Rathnam Chaguturu,
Director, High Throughput Screening Laboratory, University of Kansas

 

Intended Audience:

Opal Events' Drug Discovery: Easing the Bottleneck 2010 conference has been researched and developed specifically for; Pharmaceuticals, Biotech, Academia, Foundation, Technology Companies, and CROs' VP/ Director/ Manager/ Faculty Advisor of:

• External Research Collaboration
• Scientific Affairs
• Business Development
• Partnership/ Alliance Management
• Office of Technology Transfer
• Academic Screening Facilities
• School of Medicine/ Life Sciences/ Pharmacy
• Grants Manager
• Program Office

• Research & Development
• Analytical/ Medicinal Chemistry
• Sample/ Compound Management
• Assay Development
• Lead Discovery/ Optimization
• High Throughput Screening (HTS)
• Automation
• ADMET


Government officials, compliance officers, individuals from university and research institutes will also find much to benefit from in attending this comprehensive event.

Join us for:

• 15+ panels, discussions and presentations of the most relevant, pertinent information to the drug discovery process
• Stimulating discussions on the roles and responsibilities in drug discovery management, as well as new and innovative technologies and strategies
• 5+ hours of scheduled networking opportunities


Hotel Info:

Loews Philadelphia Hotel
1200 Market Street
Philadelphia, PA 19107
Phone: 215-627-1200

We are pleased to announce that the Opal room block is open and we are accepting reservations. Please click on the ONLINE HOTEL RESERVATION link below to book your room. The hotel will not accept individual call-ins.

 ONLINE HOTEL RESERVATION
• Rooms are available only to those participants who are registered attendees of this conference.
• Rooms will not be guaranteed without a credit card.
• Rooms are allocated on a first come first serve basis. Room types/rates are subject to availability.
• The name on the form will be the name of the guest room.
 
Executive Sponsor:
Hudson Robotics Inc.Promega
 

Panel Sponsor:

OriGene
 
General Sponsor:
BoseCutting Edge InfoGeorgia Bio
 

Media Partners:

ASD ReportsBentham Science Clinical Trials.net Current Drug Discovery Technology Current Pharmaceutical Design Drug Development Technology.comEvents in America Future Medicine Genetic Engineering and Biotechnology News Going to Meet.comInnovaroInternational Pharmaceutical Industry Life Science Leader Markets and Markets Pharm CastPharmaCirclePharma Marketing NewsPharmaceutical Formulation & Quality PharmaPhorumPharma VoicePM360R&D Directions SelectScience The Pharm YardTranslational Biomedicine
Conferences & Tradeshows
Pharmaceutical Conferences
FAQ's--|--About US--|--Privacy Statement--|--Policies--|--Information Request--|--Sponsor Info--|--Employment --|--www.opalevents.org
© 2009 Opal Events-All Rights Reserved.